Pancreatic Neoplasms: all 3,310 studies
Page 5 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the LiverRecruitingNCT06690528Phase 2
- A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC)Not yet recruitingNCT06688240
- The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)Enrolling by invitationNCT06685939
- Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic CancerNot yet recruitingNCT06677762
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT06673017Phase 1
- Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde CholangiopancreatographyNot yet recruitingNCT06670547
- NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic CancerNot yet recruitingNCT06669078Phase 2
- YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic CancerNot yet recruitingNCT06662669Phase 1/2
- Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsRecruitingNCT06662006Phase 2
- Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.RecruitingNCT06655233
- Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruitingNCT06651580
- MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT06648434Phase 1
- Phase IIT Trial of SNA014Not yet recruitingNCT06646783Early Phase 1
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
- Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic CancerRecruitingNCT06639724Phase 1
- AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening CohortRecruitingNCT06638866
- Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)Not yet recruitingNCT06621095Phase 2
- TP53 R248Q TCR-T Cell Therapy for Advanced Solid TumorNot yet recruitingNCT06619886Early Phase 1
- Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.Not yet recruitingNCT06615830
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- ImmunoPET Imaging of Pancreatic CancerRecruitingNCT06602037Not applicable
- Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic CancerRecruitingNCT06601283Phase 2/3
- The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.RecruitingNCT06601010
- Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic CancerRecruitingNCT06598033Phase 2/3
- Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant ChemotherapyRecruitingNCT06595160
- Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialRecruitingNCT06593431Phase 3
- HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRecruitingNCT06587061Phase 2
- Pancreatic Cancer and Diabetes MellitusRecruitingNCT06585072
- Adebrelimab and Chidamide for Pancreatic CancerRecruitingNCT06584227Phase 2
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Irinotecan Liposome in Combination with CapecitabineRecruitingNCT06578052Not applicable
- Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid TumorsRecruitingNCT06577532Early Phase 1
- Identification of New Theranostic Biomarkers of Pancreatic Tumor ProgressionRecruitingNCT06574373
- Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic CancerRecruitingNCT06572813Phase 1/2
- Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06571461Phase 3
- Artificial Intelligence in Endoscopic UltrasoundRecruitingNCT06564571
- 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid LesionsNot yet recruitingNCT06563232Not applicable
- MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerNot yet recruitingNCT06549751Phase 1
- Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer ScreeningRecruitingNCT06549725Not applicable
- Exploratory Platform Research on Precision Therapy of Advanced Pancreatic CancerRecruitingNCT06547736Phase 2
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06545942Phase 1
- Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing PancreatectomyNot yet recruitingNCT06541561Not applicable
- Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical StudyRecruitingNCT06534762Phase 2
- A Phase 1 Trial of ERX-315 in Participants With Advanced Solid TumorsRecruitingNCT06533332Phase 1
- Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic CancerRecruitingNCT06532617Phase 2
- Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine DifferentiationNot yet recruitingNCT06531291Phase 2
- Research of the Application of Artificial Intelligence Model "PANDA"Not yet recruitingNCT06528223Not applicable
- MRE for Diagnosis of Pancreatic MassesRecruitingNCT06526442
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT06523582
- Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing SurgeryRecruitingNCT06519500
- Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic CancerNot yet recruitingNCT06513455Phase 1/2
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid TumorsRecruitingNCT06508307Phase 1
- Safety and Efficacy of KLS-1 Monotherapy in Malignant NeoplasmsRecruitingNCT06506643Phase 1/2
- A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)RecruitingNCT06505395Phase 2
- A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic CancerRecruitingNCT06503497Early Phase 1
- A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsRecruitingNCT06500052Phase 1
- Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic DuodenopancreatectomyRecruitingNCT06499792
- The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic CancerRecruitingNCT06497777
- Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic CancerRecruitingNCT06496373Early Phase 1
- Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological SignaturesNot yet recruitingNCT06495749
- NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06494514Not applicable
- A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic CancerNot yet recruitingNCT06492941Phase 3
- Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic CancerRecruitingNCT06491472Phase 2
- Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxelRecruitingNCT06483555Phase 1/2
- Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic CancerRecruitingNCT06479239Phase 1/2
- Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic CancerRecruitingNCT06478459Early Phase 1
- Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic CancerRecruitingNCT06475326Phase 2
- Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsRecruitingNCT06472388Phase 2
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Multi-omics Model for Pancreatic Cancer Screening Using cfDNARecruitingNCT06456281
- Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic CancerRecruitingNCT06454448Phase 1/2
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerRecruitingNCT06454383Phase 1
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsRecruitingNCT06445062Phase 1/2
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsRecruitingNCT06440005Phase 1
- The Effect of Probiotics ATG-F4 in Cancer PatientsRecruitingNCT06436976Phase 2
- Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic CancerRecruitingNCT06435260Phase 2
- Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)RecruitingNCT06427460Phase 2
- Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)RecruitingNCT06427447Phase 3
- Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT06427239Phase 1/2
- Remote Exercise and Nutritional Prehabilitation for Pancreatic CancerRecruitingNCT06423963Not applicable
- Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerRecruitingNCT06423326Phase 2
- SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic CancerNot yet recruitingNCT06422156Phase 2
- Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following PancreatoduodenectomyRecruitingNCT06411795Phase 2
- KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerRecruitingNCT06411691Phase 1
- Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic PancreatitisRecruitingNCT06411470
- Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic CancerNot yet recruitingNCT06409429Phase 2/3
- Nimotuzumab Plus AG in Pancreatic Cancer With Liver MetastasisRecruitingNCT06405685Phase 2
- Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II StudyRecruitingNCT06404840Phase 2
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- Multimodal Imaging in Rectal Cancer & Pancreatic CancerNot yet recruitingNCT06395337Phase 1/2
- Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic CancerRecruitingNCT06393166Phase 2
- Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront SurgeryRecruitingNCT06391892Phase 3
- Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic CancerRecruitingNCT06389760Phase 2
- Pancreatic Cancer Detection ConsortiumRecruitingNCT06388967
- Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic CancerRecruitingNCT06387810Phase 2
- Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic CancerNot yet recruitingNCT06387368Phase 4
- Namodenoson Treatment of Advanced Pancreatic CancerRecruitingNCT06387342Phase 2